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ABSTRACT 
Background/Purpose: 
Conjugation of polymer prodrugs to tumor homing cells, such as Mesenchymal Stem 
Cells (MSCs), could provide a vehicle for actively targeted delivery of polymer prodrugs. 
 
Methods: 
Human Bone Marrow MSCs were conjugated to either a doxorubicin polymer prodrug or 
free doxorubicin and were co-cultured with T-cells. Viability was assessed through the 
use of a Vi-cell counter.  
 
In Vivo Migration Analysis was performed NOD SCID mice implanted with subcutaneous 
MDA MB-231 breast cancer xenografts. Following tumor establishment, mice were 
injected via lateral tail vein injection with either saline or polymer loaded MSCs. Five 
days following stem cell injection, mice were euthanized, tumors were harvested and 
sections were analyzed using fluorescent microscopy and immuno-histochemical 
staining for cd105. 
 
Results: 
T-cell viability was reduced when co-cultured with MSCs conjugated to free doxorubicin 
although cells co-cultured with MSCs conjugated to doxorubicin polymer did not exhibit 
reduced viability. Polymer loaded MSCs displayed intact tumor homing migratory ability 
in vivo (Figure 1). 
 
Conclusion: 
MSCs conjugated to doxorubicin released the drug, resulting in reduced neighboring T-
cells viability. MSCs loaded with polymer maintained their migratory capacity were able 
to migrate to tumors in vivo. MSCs therefore represent a potential vehicle for targeted 
drug delivery. Future work will focus on developing methods for releasing the drug upon 
successful delivery to the target in vivo. 
 
